By ThinkSabio #ThinkSabio Latest News
Autonomix Reports Positive Preliminary Results From Clinical Trial Of RF Ablation Technology, Showing 100% Of Responder Group Eliminated Opioid Use And Reduced Pain Scores From 8.0 To 1.33 At 4-6 Weeks Post-Procedure; Trial Expected To Complete Enrollment By Year-End 2024